SEC Form D · filed August 11, 2017
Caelum Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Steve Traxler · Chicago, ILDirectorWilliam W. Natbony · New York, NYDirectorMartin W. Goldman · New York, NYDirectorStuart Ellman · New York, NYExecJeffrey Dachis · New York, NYDirectorJeffrey S. Paley · New York, NYDirectorKenneth W. Cappell · New Yor, NYDirectorMichael Spector · New York, NYExec · DirectorJohn S. Struck · Hamilton, BermudaDirectorOlaf Carlson-Wee · Danville, CAExecEthan Kay · Irvine, CADirectorWilliam A. Krusen · Tampa, FLDirectorKathleen M. Shanahan · Tampa, FLDirectorAlbert G. Narvades · Tampa, FLExec · DirectorJames C. Smith · Tampa, FLDirectorNabiha Saklayen · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗